| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: a chemotherapy protocol consisting of the above compounds; used for the treatment of patients with Hodgkin's disease
| 1. | Neutropenia
08/01/2001
- "RESULTS: Grade 3-4 neutropenia and intravenous antibiotic use were significantly more common with the CAV regimen (P < 0.005). "
Order ALL the reference details at left... |
| 2. | Hodgkin Disease (Hodgkin's Disease)
05/01/1994
- "Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease."
Order ALL the reference details at left... |
| 1. | Melphalan (Alkeran)
|
| 2. | Lomustine (CCNU)
|
| 3. | Etoposide (VP 16)
|
| 1. | Salvage Therapy
|
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |